EATG » Theratechnologies press releases: Trogarzo

Theratechnologies press releases: Trogarzo

The Committee for Medicinal Products for Human Use of the European Medicines Agency will review the application for marketing authorization of Trogarzo™ (ibalizumab-uiyk) injection under the accelerated assessment procedure.

 

Trogarzo™ (ibalizumab-uiyk) injection is now included in the most recent version of the treatment guidelines issued by the International Antiviral Society-USA Panel.

News categories: HIV treatment, Guidelines, EMA/FDA